# Safety and Efficacy of Remimazolam in OPCAB Surgery

> **NCT05396690** · NA · UNKNOWN · sponsor: **Ajou University School of Medicine** · enrollment: 94 (estimated)

## Conditions studied

- Coronary Artery Bypass Surgery

## Interventions

- **DRUG:** Remimazolam Injection [Byfavo]
- **DRUG:** Sevoflurane

## Key facts

- **NCT ID:** NCT05396690
- **Lead sponsor:** Ajou University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06-15
- **Primary completion:** 2023-05-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2022-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05396690

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05396690, "Safety and Efficacy of Remimazolam in OPCAB Surgery". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05396690. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*